Merck, an American pharmaceutical company and INBio (National Biodiversity Institute), established by the Coast Rica's government had a deal in 1991.The deal was that INBio will provide Merck with the different samples of plants, micro-organisms, animals and soil from the areas of Coast Rica. These samples will be used by Merck for the research and development of new drugs. Merck will in turn, provide different monetary benefits and royalties to INBio. This deal was signed for a period of two years.
However, was it ethically justifiable? Who, if anyone, owns the many species found in nature?
Of course, there is no "right answer." Research on rare plant species or other specimens from nature have an ethical code to guide them and there are not enough details in this story to know if this was ethically justified or not.
For instance, were there other ways to do this research others than obtaining samples of these particular selected species? Were the samples taken with a minimum level of disturbance to the system? Were the quantity of samples same enough not to tip the population in a new direction? In other words, was propagation ...
Your tutorial is 459 words plus a reference and discusses what would make this ethical and what would make it not ethically justified.